Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$111.29 USD
+1.73 (1.57%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $111.22 -0.07 (-0.06%) 5:38 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.53 | 1.58 | 9.99 |
Current Quarter Estimate | 5.49 | -1.17 | 61.00 |
Year Ago Quarter Estimate | 4.84 | -0.06 | 54.84 |
Next Quarter Estimate | 6.03 | -1.92 | 63.00 |
Next Year Estimate | 21.88 | 12.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 6.78 | 20.70 | 15.67 |
Next Year | 12.03 | 16.10 | 11.34 |
Last 5 Years | 5.40 | 7.80 | 8.10 |
Next 5 Years | 5.00 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.14 | -1.44 |
Price/Book (MRQ) | 1.80 | 1.59 |
Price/Cash Flow (MRFY) | 3.94 | 9.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 10.10% | -61.35% |
Return on Equity (TTM) | 28.65% | -58.93% |
Debt to Equity (MRQ) | 1.36 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.